leisure time -WSS

leisure time

author：explore 2025-09-27 17:02:22 - browse：7646

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine?

That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday. “Could we think about vaccine-like properties, where imagine you had, once a year, an injection with an equivalent of a GLP-1 that really helps you to maintain weight loss and have cardiovascular benefits?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： How to bring more disabled researchers into academia

WSS

Pushing for an NIH office for post

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

WuXi out of biotech trade group, U.S. and China relations to blame

Novo Nordisk obesity pill bests Wegovy in early trial

How many hemophilia patients actually want gene therapy?

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

hotspot

leisure time

explore

ChatGPT in medicine: STAT answers readers' burning questions

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Heart attack and stroke risk calculators need revising

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

In age of alternative facts, a scholarly course on calling out crap

WuXi out of biotech trade group, U.S. and China relations to blame

Psychedelics group wrestles with new pharma identity

Air quality improving but still lags in Black, Hispanic communities

Moonlake's readout produced a cash windfall. Risks remain

NEJM study link tiny plastics in blood vessels to heart problems

explore

HHS secretary Becerra pressed on Change HealthCare cyberattack

Just how do doctors, lawmakers, and the public define abortion?

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Change Healthcare payments predicted restored March 15

Just how do doctors, lawmakers, and the public define abortion?

knowledge

knowledge

hotspot

Wikipedia